RemeGen Co (HKSE:09995) Short-Term Debt & Capital Lease Obligation : HK$1,529 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is RemeGen Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. RemeGen Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$1,529 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. RemeGen Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$1,322 Mil.

RemeGen Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for RemeGen Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Short-Term Debt & Capital Lease Obligation Chart

RemeGen Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

179.14

64.23

67.18

377.05

1,529.48

RemeGen Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial								67.18	80.63	377.05	1,072.11	1,529.48

RemeGen Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

RemeGen Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of RemeGen Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

RemeGen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (HKSE:09995) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

REGMF:USA REG:Germany 688331:China

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

https://www.remegen.com

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat severe diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.

Executives

I-nova Limited	2101 Beneficial owner
Yantai Rongda Venture Capital Center (limited Partnership)	2103 Interests held jointly with another person
Yang Minhua	2103 Interests held jointly with another person
Xiong Xiaobin	2103 Interests held jointly with another person
Wen Qingkai	2103 Interests held jointly with another person
Deng Yong	2103 Interests held jointly with another person
Fang Jianmin	2103 Interests held jointly with another person
Lin Jian	2103 Interests held jointly with another person
Rongchang Holding Group Ltd.	2103 Interests held jointly with another person
Wang Liqiang	2103 Interests held jointly with another person
Wang Weidong	2201 Interest of corporation controlled by you
Wang Xudong	2103 Interests held jointly with another person
Wei Jianliang	2103 Interests held jointly with another person
Morgan Stanley	2201 Interest of corporation controlled by you
Allianz Se	2201 Interest of corporation controlled by you

RemeGen Co Headlines

No Headlines